Smith & Nephew’s (SN) “Buy” Rating Reiterated at Jefferies Financial Group

Jefferies Financial Group reiterated their buy rating on shares of Smith & Nephew (LON:SN) in a report published on Friday morning, Marketbeat Ratings reports. The brokerage currently has a GBX 1,250 ($15.70) target price on the stock.

SN has been the subject of several other reports. JPMorgan Chase & Co. upped their price objective on Smith & Nephew from GBX 1,300 ($16.33) to GBX 1,381 ($17.35) and gave the stock an overweight rating in a research note on Thursday. Barclays restated an equal weight rating and issued a GBX 1,150 ($14.45) price objective on shares of Smith & Nephew in a research note on Friday, February 9th. Royal Bank of Canada reiterated an outperform rating and issued a GBX 1,500 ($18.84) price target on shares of Smith & Nephew in a research note on Friday, April 5th. Finally, Berenberg Bank reiterated a buy rating and issued a GBX 1,450 ($18.21) price target on shares of Smith & Nephew in a research note on Thursday. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of Moderate Buy and a consensus price target of GBX 1,346.20 ($16.91).

Smith & Nephew Price Performance

LON SN opened at GBX 996.80 ($12.52) on Friday. The business’s fifty day moving average price is GBX 1,018.36 and its 200-day moving average price is GBX 1,035.73. The stock has a market capitalization of £8.72 billion, a price-to-earnings ratio of 4,153.33, a PEG ratio of 0.46 and a beta of 0.51. The company has a debt-to-equity ratio of 59.11, a current ratio of 1.77 and a quick ratio of 0.84. Smith & Nephew has a 1-year low of GBX 887 ($11.14) and a 1-year high of GBX 1,316.75 ($16.54).

Smith & Nephew Increases Dividend

The business also recently declared a dividend, which will be paid on Wednesday, May 22nd. Investors of record on Thursday, March 28th will be given a $0.23 dividend. The ex-dividend date is Thursday, March 28th. This represents a yield of 1.62%. This is a positive change from Smith & Nephew’s previous dividend of $0.14. Smith & Nephew’s dividend payout ratio (DPR) is currently 12,500.00%.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.